Prosecution Insights
Last updated: August 15, 2026

Nulixir Inc.

9 pending office actions • 5 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
4
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (33%)
5
Medium (56%)
1
Easy (11%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only3 (33%)
§112 only1 (11%)
Double-patenting + other2 (22%)
Multi-statute (no §101)3 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WORSHAM, JESSICA N 1 56.4% +56.6%
CHO, DAVID H 1 37.5% +73.5%
STEVENS, MARK V 1 65.5% +41.9%
SASAN, ARADHANA 1 64.3% +26.6%
MEYERS, ELIZABETH ANNE 1 28.6% +90.9%
ATKINSON, JOSHUA ALEXANDER 1 55.3% +34.9%
KIM, DANIELLE A 1 36.7% +57.5%
TIEN, LUCY MINYU 1 60.5% +37.0%
TCHERKASSKAYA, OLGA V 1 55.2% +46.3%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17944985 SOLID ORAL BEADS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME TIEN, LUCY MINYU 1d overdue
18447240 ENCAPSULATED VITAMIN D WORSHAM, JESSICA N
17945011 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME MEYERS, ELIZABETH ANNE

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17945036 STABLE NON-AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME STEVENS, MARK V 23d overdue
17944985 SOLID ORAL BEADS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME TIEN, LUCY MINYU 1d overdue
17945012 STABLE AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME SASAN, ARADHANA 22d
18447240 ENCAPSULATED VITAMIN D WORSHAM, JESSICA N
18168394 ENCAPSULATED PRECURSORS OF NICOTINAMIDE ADENINE DINUCLEOTIDE AND METHODS OF MAKING THE SAME CHO, DAVID H
17945011 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME MEYERS, ELIZABETH ANNE
17945038 ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME ATKINSON, JOSHUA ALEXANDER
17945037 STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME KIM, DANIELLE A

Top Art Units

Art UnitApps
1615 3
1613 2
1612 2
1693 1
1617 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18447240 ENCAPSULATED VITAMIN D WORSHAM, JESSICA N 1615 §102§103§112 Non-Final OA Pending Aug 09, 2023
18168394 ENCAPSULATED PRECURSORS OF NICOTINAMIDE ADENINE DINUCLEOTIDE AND METHODS OF MAKING THE SAME CHO, DAVID H 1693 §103DP Final Rejection Pending Feb 13, 2023
17945036 STABLE NON-AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME STEVENS, MARK V 1613 §103 Non-Final OA 23d overdue Pending Sep 14, 2022
17945012 STABLE AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME SASAN, ARADHANA 1615 §103 Final Rejection 22d Pending Sep 14, 2022
17945011 ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME MEYERS, ELIZABETH ANNE 1617 §103§112 Non-Final OA Pending Sep 14, 2022
17945038 ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME ATKINSON, JOSHUA ALEXANDER 1612 §112DPOther Non-Final OA Pending Sep 14, 2022
17945037 STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME KIM, DANIELLE A 1613 §103 Final Rejection Pending Sep 14, 2022
17944985 SOLID ORAL BEADS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME TIEN, LUCY MINYU 1612 §103§112 Final Rejection 1d overdue Pending Sep 14, 2022
17470994 METHODS AND SYSTEMS FOR FORMING MULTI-LAYERED PARTICLES TCHERKASSKAYA, OLGA V 1615 §112 Final Rejection Pending Sep 09, 2021

Managing Nulixir Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month